Health2025-12-02T13:37:19+00:00

Health

Analyses for the pharmaceutical industry and the broader healthcare sector. They focus on the evaluation of business activity in the healthcare sector, as well as on issues related to enhancing the quality and accessibility of healthcare services, the link with the pharmaceutical industry and the health insurance market, and the challenges and opportunities arising from digital health and self-care.

Digital Health and Real World Data in Greece: The transformation in the health ecosystem and the impact on the economy

The scope of the project is to describe the current environment regarding digital health and Real World Data (RWD)- Real Word Evidence (RWE) in Greece and try to estimate the economic impact of their exploitation for the healthcare [...]

10/03/2022|

Compensation cost indicators of long-term hospital insurance programmes for the years 2011-2020

The scope of this study is to estimate indicators for monitoring the compensation cost of personal hospital insurance programmes. These indicators exclusively concern guaranteed renewable programmes. They measure the annual percentage changes of the average expenditure of the [...]

10/11/2021|

Compensation cost indicators of long-term hospital insurance programmes for the years 2011-2019

The scope of this study is to design and estimate indicators for monitoring the compensation cost of personal hospital insurance programmes. These indicators exclusively concern guaranteed renewable programmes. They measure the annual percentage changes of the average expenditure [...]

29/12/2020|

Compensation cost indicators of long-term hospital insurance programmes for the years 2011-2018

The scope of this study is to design and estimate indicators for monitoring the compensation cost of personal hospital insurance programmes. These indicators exclusively concern guaranteed renewable programmes. They measure the annual percentage changes of the average expenditure [...]

13/11/2019|
Go to Top